ppar gamma - CISMeF

Preferred Label : ppar gamma;

MeSH definition : A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR ALPHA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES. It is a target of THIAZOLIDINEDIONES for control of DIABETES MELLITUS.;

MeSH synonym : thiazolidinedione receptor; ppargamma; receptor, thiazolidinedione; peroxisome proliferator-activated receptor gamma; peroxisome proliferator activated receptor gamma;

MeSH hyponym : mPPARgamma2; PPARgamma2; PPARgamma3; mPPARgamma1;

Is substance : O;

Details

Origin ID

D047495;

UMLS CUI

C0166417;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Peroxisome Proliferator-Activated Receptor Gamma [NCIt concept]
Indexing information
- (5-(3-(4-(biphenyl-4-ylcarbonyl)phenoxy)propoxy)-1H-indol-1-yl)acetic acid [MeSH Supplementary Concept]
- (E)-12-nitrooctadec-12-enoic acid [MeSH Supplementary Concept]
- (S)-2-(2,4-hexadienoyl)-7-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 1,1-bis(3'-indolyl)-1-(4-biphenyl)methane [MeSH Supplementary Concept]
- 1,1-bis(3'-indolyl)-1-(4-t-butylphenyl)methane [MeSH Supplementary Concept]
- 1-(2'-chloro-5'-nitrobenzenesulfonyl)-2-methylbenzimidazole [MeSH Supplementary Concept]
- 1-(4-(2-(5-methyl-2-p-tolyloxazol-4-yl)ethoxy)benzyl)piperidine-2-carboxylic acid [MeSH Supplementary Concept]
- 1-(benzo(b)thiophen-2-yl)-2-(methylsulfinyl)ethanone [MeSH Supplementary Concept]
- 1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester [MeSH Supplementary Concept]
- 1-0-hexadecyl-2-azelaoyl-sn-glycero-3-phosphocoline [MeSH Supplementary Concept]
- 1-oxo-3-phenyl-6-(3-phenylpropoxy)-1H-indene-2-carboxylic acid ethyl ester [MeSH Supplementary Concept]
- 2-(1-(3-(4-(biphenyl-4-carbonyl)-2-propylphenoxy)propyl)-1,2,3,4-tetrahydroquinolin-5-yloxy)-2-methylpropionic acid [MeSH Supplementary Concept]
- 2-(2,4-hexadienoyl)-7-(2-(5-methyl-2-(5-methylhexen-1-yl)oxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 2-(4-(2-Fluoro-benzenesulphonyl)-piperazin-1-yl)-3-(4-(2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy)phenyl)propionic acid [MeSH Supplementary Concept]
- 2-(4-chlorophenoxy)-3-phenylpropanoic acid [MeSH Supplementary Concept]
- 2-bromo-5-nitro-N-phenylbenzamide [MeSH Supplementary Concept]
- 2-cyanolup-1-en-3-oxo-20-oic acid [MeSH Supplementary Concept]
- 2-ethoxy-3-(4-(3-methyl-5-(4-(3-methylisoxazol-5-yl)phenyl)thiophen-2-ylmethoxy)phenyl)propionic acid [MeSH Supplementary Concept]
- 3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(2-(2-nitrophenoxy)acetylamino)propionic acid [MeSH Supplementary Concept]
- 3-(4-(3-(4-chloro-2-phenoxyphenoxy)butoxy)-2-ethylphenyl)propionic acid [MeSH Supplementary Concept]
- 3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 4-hydroxy-5,7,10,13,16,19-docosahexaenoic acid [MeSH Supplementary Concept]
- 5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione [MeSH Supplementary Concept]
- 5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid [MeSH Supplementary Concept]
- 5-(5-bromo-2-methoxybenzylidene)-3-(4-methyl-benzyl)thiazolidine-2,4-dione [MeSH Supplementary Concept]
- CG 301269 [MeSH Supplementary Concept]
- INT 131 [MeSH Supplementary Concept]
- KR 62776 [MeSH Supplementary Concept]
- KV-5070 [MeSH Supplementary Concept]
- N-(2-(4-((2,4-dioxo-1,3-thiazolidin-5-yl)methyl)phenoxy)ethyl)-5-(1,2-dithiolan-3-yl)-N-methylpentanamide [MeSH Supplementary Concept]
- Rosiglitazone [MeSH Descriptor]
- efatutazone [MeSH Supplementary Concept]
- herdmanine E [MeSH Supplementary Concept]
- idescarpin [MeSH Supplementary Concept]
- lobeglitazone [MeSH Supplementary Concept]
- methyl 7-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)coumarin-7-carboxylate [MeSH Supplementary Concept]
- muraglitazar [MeSH Supplementary Concept]
- naveglitazar [MeSH Supplementary Concept]
- peliglitazar [MeSH Supplementary Concept]
- sipoglitazar [MeSH Supplementary Concept]
Record concept(s)
- PPAR gamma [MeSH concept]
- PPARgamma2 [MeSH concept]
- PPARgamma3 [MeSH concept]
- mPPARgamma1 [MeSH concept]
- mPPARgamma2 [MeSH concept]
Related MeSH Supplementary Concept(s)
- PPAR gamma, rat [MeSH Supplementary Concept]
- PPARG protein, human [MeSH Supplementary Concept]
- Pparg protein, mouse [MeSH Supplementary Concept]
See also
- lipodystrophy, familial partial [MeSH Descriptor]
See also (suggested by CISMeF)
- Pioglitazone [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients